Beta Drugs consolidated net profit rises 51.80% in the September 2026 quarter

Sales rise 32.98% to Rs 137.49 crore

Net profit of Beta Drugs rose 51.80% to Rs 18.55 crore in the quarter ended September 2026 as against Rs 12.22 crore during the previous quarter ended September 2025. Sales rose 32.98% to Rs 137.49 crore in the quarter ended September 2026 as against Rs 103.39 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	137.49	103.39	33
OPM %	22.02	20.61	-
PBDT	30.39	20.68	47
PBT	25.78	16.44	57
NP	18.55	12.22	52

Powered by Capital Market - Live News